|1.||Selzer, R H: 3 articles (08/2000 - 06/2000)|
|2.||Hodis, H N: 3 articles (08/2000 - 06/2000)|
|3.||Mack, W J: 3 articles (08/2000 - 06/2000)|
|4.||Xiang, M: 2 articles (08/2000 - 06/2000)|
|5.||Hemphill, Linda C: 1 article (01/2015)|
|6.||Davis, Joseph: 1 article (09/2014)|
|7.||Moore, Andrew B: 1 article (09/2014)|
|8.||Brown, B Greg: 1 article (09/2014)|
|9.||Pollan, Laura J: 1 article (09/2014)|
|10.||Neradilek, Blazej: 1 article (09/2014)|
01/01/1973 - "Effect of colestipol (U-26,597A) on experimental atherosclerosis in rabbits."
06/19/1987 - "Atherosclerosis regression, as indicated by perceptible improvement in overall coronary status, occurred in 16.2% of colestipol-niacin treated vs 2.4% placebo treated (P = .002)."
02/01/2004 - "A 2-year follow-up study of 153 patients with femoral atherosclerosis treated with colestipol-niacin demonstrated a decreased progression of angiographically assessed femoral atherosclerosis (p < 0.02). "
02/01/1991 - "Effects of colestipol-niacin therapy on human femoral atherosclerosis."
04/01/1982 - "Long-term colestipol therapy in conjunction with diet may reduce xanthoma size, arrest progression of coronary artery atherosclerosis, and may reduce mortality from coronary heart disease. "
|2.||Coronary Artery Disease (Coronary Atherosclerosis)
12/19/1990 - "Beneficial effects of colestipol-niacin on coronary atherosclerosis. "
11/20/1987 - "Colestipol-niacin therapy and coronary atherosclerosis."
06/19/1987 - "Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts."
06/27/1986 - "Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease."
06/01/1988 - "Studies that used cholestyramine and the combination of colestipol and niacin resulted in decreased progression of coronary artery disease. "
|3.||Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
12/01/1992 - "We examined the growth of 30 children with familial hypercholesterolemia, some of whom were also treated with colestipol, a bile acid-binding resin. "
03/04/1992 - "[Colestipol in the treatment of heterozygous familial hypercholesterolemia]."
01/01/1982 - ""Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia."
09/01/1980 - "[Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol]."
06/27/1986 - "The combination of probucol and colestipol plus diet appears to be effective in treating most patients with familial hypercholesterolemia."
09/01/1976 - "Colestipol seems to be an effective and safe drug in the treatment of the famiial type II hyperlipoproteinemia, without escape phenonmenon."
09/01/1976 - "Colestipol in familial type II hyperlipoproteinemia: a three-year trial."
02/08/1991 - "[Small doses of the resin Colestid in the treatment of hyperlipoproteinemia]."
02/01/1979 - "Long-term effects of diet and colestipol (a bile acid sequestrant) were studied in 25 patients with familial type II hyperlipoproteinemia. "
02/01/1979 - "Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia."
07/15/1992 - "Low-dose colestipol therapy is effective in the treatment of patients with moderate hypercholesterolemia.(ABSTRACT TRUNCATED AT 250 WORDS)"
07/15/1992 - "A double-blind, placebo-controlled, randomized trial of 3 low doses of colestipol hydrochloride was conducted in women and men with moderate hypercholesterolemia. "
03/01/1978 - "Colestipol hydrochloride for treatment of hypercholesterolemia in a family practice: five-year study."
07/15/1992 - "Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia."
09/01/1988 - "The use of diet and low colestipol doses may be considered in patients with moderate hypercholesterolemia who do not respond to diet alone."
|2.||Niacin (Nicotinic Acid)
|1.||Blood Component Removal (Apheresis)
|2.||Drug Therapy (Chemotherapy)
|4.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)
|5.||Enteral Nutrition (Feeding, Tube)